In the BioHarmony Drug Report Database

"Preview" Icon

Valdecoxib

Bextra (valdecoxib) is a small molecule pharmaceutical. Valdecoxib was first approved as Bextra on 2001-11-16. It is used to treat dysmenorrhea, osteoarthritis, and rheumatoid arthritis in the USA. The pharmaceutical is active against prostaglandin G/H synthase 2. In addition, it is known to target carbonic anhydrase 12 and carbonic anhydrase 2.

 

Trade Name

 

Bextra
 

Common Name

 

valdecoxib
 

ChEMBL ID

 

CHEMBL865
 

Indication

 

dysmenorrhea, osteoarthritis, rheumatoid arthritis
 

Drug Class

 

Cyclooxygenase-2 inhibitors

Image (chem structure or protein)

Valdecoxib structure rendering